[1] GORDON C, AMISSAH-ARTHUR MB, GAYED M, et al.The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults[J].Rheumatology, 2018, 57(1):14. doi: 10.1093/rheumatology/kex291
[2] FLYNN A, GILHOOLEY E, O'SHEA F, et al.The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus[J].Clin Rheumatol, 2018, 37(3):817. doi: 10.1007/s10067-018-3999-0
[3] KIM KK, SHEPPARD D, CHAPMAN HA.TGF-β1 Signaling and Tissue Fibrosis[J].Cold Spring Harb Perspect Biol, 2018, 10(4):1.
[4] HU HH, CHEN DQ, WANG YN, et al.New insights into TGF-β/Smad signaling in tissue fibrosis[J].Chem Biol Interact, 2018, 292(8):76.
[5] SAXENA V, LIENESCH DW, ZHOU M, et al.Dual roles of immunoregulatory cytokine TGF-β in the pathogenesis of autoimmunity-mediated organ damage[J].J Immunol, 2008, 180(3):1903. doi: 10.4049/jimmunol.180.3.1903
[6] HOCHBERG MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum, 1997, 40(9):1725.
[7] BOMBARDIER C, GLADMAN DD, UROWITZ MB, et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE[J].Arthritis Rheum, 1992, 35(6):630. doi: 10.1002/art.1780350606
[8] SHULL MM, ORMSBY I, KIER AB, et al.Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease[J].Nature, 1992, 359(6397):693. doi: 10.1038/359693a0
[9] KELLER JR, BARTELMEZ SH, SITNICKA E, et al.Distinct and overlapping direct effects of macrophage inflammatory protein-α and transforming growth factor β on hematopoietic progenitor/stem cell growth[J].Blood, 1994, 84(7):2175.
[10] LI MO, WAN YY, FLAVELL RA.T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation[J].Immunity, 2007, 26(5):579. doi: 10.1016/j.immuni.2007.03.014
[11] MARIE JC, LIGGITT D, RUDENSKY AY.Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor[J].Immunity, 2006, 25(3):441. doi: 10.1016/j.immuni.2006.07.012
[12] GYORFI AH, MATEI AE, DISTLER JHW.Targeting TGF-β signaling for the treatment of fibrosis[J].Matrix Biol, 2018, 68-69(8):8.
[13] ISAKA Y.Targeting TGF-β Signaling in Kidney Fibrosis[J].Int J Mol Sci, 2018, 19(9):1.
[14] LECH M, LORENZ G, KULKARNI OP, et al.NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-β receptor signalling[J].Ann Rheum Dis, 2015, 74(12):2224. doi: 10.1136/annrheumdis-2014-205496
[15] BECKER-MEROK A, EILERTSEN GO, NOSSENT JC.Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease[J].The J Rheumatol, 2010, 37(10):2039. doi: 10.3899/jrheum.100180
[16] JIN T, ALMEHED K, CARLSTEN H, et al.Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus[J].Lupus, 2012, 21(3):310. doi: 10.1177/0961203311425528
[17] LU LY, CHU JJ, LU PJ, et al.Expression of intracellular transforming growth factor-β1 in CD4+CD25+ cells in patients with systemic lupus erythematosus[J].J Microbiol Immunol Infect, 2008, 41(2):165.
[18] KAPLAN J, WOODWORTH L, SMITH K, et al.Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-β1 in the MRL/lpr lupus mouse model[J].Lupus, 2008, 17(9):822. doi: 10.1177/0961203308091635
[19] HUANG XR, CHUNG AC, ZHOU L, et al.Latent TGF-β1 protects against crescentic glomerulonephritis[J].J Am Soc Nephrol, 2008, 19(2):233. doi: 10.1681/ASN.2007040484
[20] BRODEUR AC, ROBERTS-PILGRIM AM, THOMPSON KL, et al.Transforming growth factor-β1/Smad3-independent epithelial-mesenchymal transition in type Ⅰ collagen glomerulopathy[J].Int J Nephrol Renovasc Dis, 2017, 10(8):251.
[21] BRODER A, MOWREY WB, KHAN HN, et al.Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function:a retrospective cohort study[J].Semin Arthritis Rheum, 2018, 47(4):545. doi: 10.1016/j.semarthrit.2017.07.007
[22] MA LJ, YANG H, GASPERT A, et al.Transforming growth factor-β-dependent and -independent pathways of induction of tubulointerstitial fibrosis in β6(-/-) mice[J].The Am J Pathol, 2003, 163(4):1261. doi: 10.1016/S0002-9440(10)63486-4
[23] YEH YC, WEI WC, WANG YK, et al.Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis[J].Am J Pathol, 2010, 177(4):1743. doi: 10.2353/ajpath.2010.091183
[24] 柯培锋, 庄俊华, 李强, 等.TGF-β1血清水平与类风湿性关节炎相关性研究[J].广东医学, 2009, 30(7):1058. doi: 10.3969/j.issn.1001-9448.2009.07.016
[25] 戴冽, 叶志强, 汤美安, 等.类风湿关节炎滑膜转化生长因子β-1表达及与病理改变的关系[J].中华风湿病学杂志, 2000, 4(6):357. doi: 10.3760/j:issn:1007-7480.2000.06.009